Clinical Trials Browser

Phase 4 × CPX-351 × Clear all

NCT03988205 2022-07-19

Patients Receiving Induction With Liposomal Daunorubicin and Cytarabine (CPX-351) for Acute Myeloid Leukemia

Phase 4 Terminated

3 enrolled 10 charts

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute